抗微生物耐药性:将分子机制与公共卫生影响联系起来
Ghazala Muteeb1, Raisa Nazir Ahmed Kazi2, Mohammad Aatif3
1Department of Nursing, College of Applied Medical Science, King Faisal University, Al-Ahsa, Saudi Arabia.
SLAS discovery : advancing life sciences R & D
|April 11, 2025
概括
抗微生物耐药性 (AMR) 是一种全球危机,由β-乳糖酶和排泄等微生物适应驱动. 解决这一问题需要综合战略,结合分子洞察力,监测和新疗法.
科学领域:
- 微生物学与传染病的研究
- 遗传学和分子生物学
- 公共卫生和流行病学
背景情况:
- 抗菌素耐药性 (AMR) 是由微生物遗传和生物化学适应驱动的日益增长的全球卫生紧急情况.
- 关键的抵抗机制包括β-乳糖酶 (例如,blaNDM,blaKPC) 和排泄 (例如,MexAB-OprM),通常通过移动遗传元素传播.
- 这些适应导致多耐药 (MDR) 和广泛耐药 (XDR) 现象型,影响医疗保健,社区和农业.
研究的目的:
- 通过分析流行病学数据和监测方法,统一分子耐药性途径与公共卫生影响.
- 将分子遗传学和临床结果结合起来,进行AMR的综合分析.
- 探索用于打击AMR的创新治疗解决方案.
主要方法:
- 研究耐药机制:酶降解,排泄过度表达,标修饰和横向基因转移.
- 检查AMR对医院和社区病原体的影响,如MRSA,耐卡巴胺的Klebsiella肺炎和耐药的Pseudomonas aeruginosa.
- 探索现代抗菌耐药性管理:WHO GLASS分子监测,基于CRISPR的基因组编辑,细菌治疗,抗菌和人工智能诊断.
主要成果:
- 确定了导致当前AMR的关键分子机制.
- 突出了AMR对医疗保健和社区环境中关键病原体的广泛影响.
- 审查了AMR管理的创新诊断和治疗策略.
结论:
- 解决AMR需要全面的科学和全球运营战略.
- 最先进的治疗方法对于有效的AMR管理至关重要.
- 全球对抗药性感染的控制需要加强预防和下一代抗菌药物战略.
相关概念视频
Antibiotic Selection
52.0K
Overview
52.0K
Defense Against Bacterial Pathogens
1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Mismatch Repair
39.8K
Overview
39.8K
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Genomic DNA in Prokaryotes
43.2K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.2K
Infection
6.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
6.6K


